ConductScience.org, home

Paper7180965

Prognostic significance of morphologic parameters in renal cell carcinoma.

Fuhrman SA and 2 others. Am J Surg Pathol, 1982. Cited by 2,311 papers, by iCite.

Cite this record

ConductScience Library. Prognostic significance of morphologic parameters in renal cell carcinoma. Papers, record 7180965. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7180965

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic significance of morphologic parameters in renal cell carcinoma.
PubMed
Journal
Am J Surg Pathol
PubMed
Year
1982
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2,311
iCite
Relative citation ratio, by iCite
63.9
iCite
Revised in PubMed
2022-04-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fuhrman SAS A
2Lasky LCL C
3Limas CC

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Kidney NeoplasmsMajor topic
Adult
Aged
Female
Humans
Male
Middle Aged
Neoplasm Invasiveness
Prognosis
Renal Veins

Source PubMed

Download CSV of topics

Cited by743

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,311 citations.

PMIDTitleJournalYearIn PapersSource
42758284Quantitative MRI for World Health Organisation/International Society of Urological Pathology Grading of Renal Cell Carcinoma: a systematic review and diagnostic meta-analysis.Eur Radiol2026https://conductscience.org/library/papers/42758284PubMed
42656201Prognostic value of preoperative inflammatory cell-to-HDL cholesterol ratios in patients with non-metastatic clear cell renal cell carcinoma.Front Oncol2026https://conductscience.org/library/papers/42656201PubMed
42552493Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era.Ann Surg Oncol2026https://conductscience.org/library/papers/42552493PubMed
42449624Risk Stratification in Renal Cell Carcinoma: A Narrative Review.Cancers (Basel)2026https://conductscience.org/library/papers/42449624PubMed
42436714Multimodal deep learning for predicting WHO/ISUP grading in renal tumors on CT using a self-attention-based model: variable Vision Transformer (vViT).Eur J Radiol Open2026https://conductscience.org/library/papers/42436714PubMed
42238232Role of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in subtyping renal cell carcinoma.World J Radiol2026https://conductscience.org/library/papers/42238232PubMed
42212433Updates and controversies in contemporary grading of clear cell renal cell carcinoma and papillary renal cell carcinoma.Histopathology2026https://conductscience.org/library/papers/42212433PubMed
41975702Pathology-Driven Genomic Panels for Personalized Prognostic Stratification and Exploratory Therapeutic Prediction in Clear-Cell Renal Cell Carcinoma with Tumor Thrombus.Diagnostics (Basel)2026https://conductscience.org/library/papers/41975702PubMed
41913822Hidden in Plain Sight: Metastatic Renal Cell Carcinoma Masquerading as Multinodular Thyroid Disease.Cureus2026https://conductscience.org/library/papers/41913822PubMed
41898704Targeting G6PD (Glucose-6-Phosphate Dehydrogenase) as a Biomarker of Therapeutic Vulnerability in Renal Cell Carcinoma.Int J Mol Sci2026https://conductscience.org/library/papers/41898704PubMed
41871874Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0.J Immunother Cancer2026https://conductscience.org/library/papers/41871874PubMed
41841143Does Tumor Grade Have any Prognostic Significance in Chromophobe Renal Cell Carcinoma: A Clinicopathological Study.J Cancer Allied Spec2025https://conductscience.org/library/papers/41841143PubMed
41840584TCOF1 affects Golgi secretory pathway contributing to the angiogenesis in renal cancer.Cell Commun Signal2026https://conductscience.org/library/papers/41840584PubMed
41732251Metastatic renal cell carcinoma: risk of rapid progression to pathological fractures and factors influencing post-treatment survival - a Swedish Nationwide cohort study.J Bone Oncol2026https://conductscience.org/library/papers/41732251PubMed
41614853A PDCD4-Based Gene Expression Signature Predicts Overall Survival in Renal Cell Carcinoma: A TCGA-Based Discovery and External Validation Study.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41614853PubMed
41503066pVHL status in clear cell renal cell carcinoma regulates HIF-α and E-cadherin expression levels and their implications for tumor progression.Ups J Med Sci2025https://conductscience.org/library/papers/41503066PubMed
41472921Artificial intelligence-driven digital pathology in urological cancers: current trends and future directions.Prostate Int2025https://conductscience.org/library/papers/41472921PubMed
41083961The association between serum uric acid and survival outcomes in patients with metastatic renal cell carcinoma treated with targeted therapy.BMC Cancer2025https://conductscience.org/library/papers/41083961PubMed
41057662Diagnosis and grading of adrenal cortical carcinoma.Virchows Arch2026https://conductscience.org/library/papers/41057662PubMed
41010935Impact of Adipokine Expression on Tumor Characteristics and Survival Outcomes in Patients with Renal Cell Carcinoma.Medicina (Kaunas)2025https://conductscience.org/library/papers/41010935PubMed

See all 743 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7180965

GET https://conductscience.org/api/papers/v1/7180965/cited_by?page=2